Evidence map›Paper›PMID 30589164›Full record

ArticleAngewandte Chemie (International ed. in English)2019

An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.

Melissa D'Ascenzio, Kathryn M Pugh, Rebecca Konietzny, Georgina Berridge, Cynthia Tallant, Shaima Hashem, Octovia Monteiro, Jason R Thomas, Markus Schirle, Stefan Knapp and 5 more

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Identification and Development of BRD9 Chemical Probes.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Melissa D'AscenzioStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.ORCID 0000-0003-2449-6461
Kathryn M PughStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Rebecca KonietznyTarget Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
Georgina BerridgeStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Cynthia TallantStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Shaima HashemStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Octovia MonteiroStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Jason R ThomasNovartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA.
Markus SchirleNovartis Institute for BioMedical Research (NIBR), 180 Massachusetts Ave, Cambridge, MA, 02139, USA.
Stefan KnappStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Brian MarsdenStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Oleg FedorovStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Chas BountraStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.
Benedikt M KesslerTarget Discovery Institute (TDI), University of Oxford, Oxford, OX3 7FZ, UK.
Paul E BrennanStructural Genomic Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.ORCID 0000-0002-8950-7646

Funding

Medical Research Council MC-PC-14131Wellcome Trust 106169/ZZ14/Z
6 · The paper itself

Abstract

Bromodomain-containing proteins are epigenetic modulators involved in a wide range of cellular processes, from recruitment of transcription factors to pathological disruption of gene regulation and cancer development. Since the druggability of these acetyl-lysine reader domains was established, efforts were made to develop potent and selective inhibitors across the entire family. Here we report the development of a small molecule-based approach to covalently modify recombinant and endogenous bromodomain-containing proteins by targeting a conserved lysine and a tyrosine residue in the variable ZA or BC loops. Moreover, the addition of a reporter tag allowed in-gel visualization and pull-down of the desired bromodomains.

Indexed as

Protein DomainsAcetylationAmino Acid SequenceBinding SitesCarbamatesConserved SequenceHistonesLysineMolecular Docking SimulationProtein BindingPyridazinesTriazolesbromosporineCarbamatesHistonesLysinePyridazinesTriazolesactivity-based protein profilingbromodomainchemical proteomicscovalent probesepigenetics

Identifiers

PMID30589164
PMCPMC6492141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.